Latest News and Press Releases

BASEL, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Aukera Therapeutics, a preclinical-stage biotech spin-off from the University of Basel is officially coming out of stealth as it enters...

Sampo plc, stock exchange release, 11 December 2025 at 8:30 am EET Sampo plc’s share buybacks 10 December 2025 On 10 December 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has...

Funding to provide runway through potential Graves’ Disease commercial launch NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company...

Allschwil, Switzerland, December 11, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...

Inside / regulated information Aalst, Belgium, December 11, 2025 – The Board of Directors of Ontex (Euronext: ONTEX) has decided to appoint Mr. Laurent Nielly as Chief Executive Officer, effective as...

Press release – No. 19 / 2025 Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health Zealand Pharma targets five launches,...

Atos and N3XT Sports have signed a strategic partnership to collaborate on technology development projects in Saudi Arabia sport market.

Inside / regulated information Aalst, Belgium, December 11, 2025 – Ontex Group NV, a leading international developer and producer of personal care products, revises its full year expectations for...

Ad hoc announcement pursuant to Art. 53LR BASEL, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) -- BV100 Phase 3 in Ventilator Associated Bacterial Pneumonia initiated with first country submission...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 11, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...